Close Menu

NEW YORK – Veritas Genetics has restructured its business and is reopening its US operations with a small team of core employees, GenomeWeb has learned.

According to CEO Mirza Cifric, the company has secured an undisclosed amount of near-term financing from unnamed investors, allowing it to restart the US business. In addition, he said the firm is working on closing "a significant round of funding." He declined to elaborate on the potential investors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.